We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Yeliva is currently in mid-to-late stage testing globally for hospitalized patients with severe COVID-19 pneumonia who require supplemental oxygen. Read More
RedHill Biopharma has announced positive steps in two late-stage trials evaluating its Yeliva (opaganib) for severe COVID-19 patients and said it plans to file an Emergency Use Authorization (EUA) for the drug as early as the end of the year. Read More
An independent Safety Monitoring committee has recommended the continuation of a phase 2 trial in the U.S., studying the drug in 40 severe COVID-19 patients. Read More
An analysis of seven international clinical trials published yesterday found that corticosteroids help reduce the risk of death in the most severe COVID-19 patients. Read More
Sanofi and Regeneron Pharmaceuticals said they have no plans to conduct further trials of their rheumatoid arthritis drug Kevzara for COVID-19 after it failed in a late-stage study. Read More
In applications for patents — including some generally relevant to its COVID-19 vaccine candidate — Moderna failed to disclose millions of dollars it got from the Defense Advanced Research Projects Agency (DARPA), alleges an advocacy group that wants the Department of Defense (DOD) to investigate. Read More